English

ONYX PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2013-08-09

71 filing records in this dataset, filed from 1996-08-14 to 2013-08-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

153 million USD

2013 Q2 · USD

Exact inputs and evidence

Revenue: 153026000 USD Source

Operating margin

-31.06%

2013 Q2 · %

Exact inputs and evidence

Operating Income: -47533000 USD Source
Revenue: 153026000 USD Source

Operating cash flow

-3.35 million USD

2013 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -114524000 USD Source
Operating Cash Flow: -111173000 USD Source

Free cash flow

-7.96 million USD

2013 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -114524000 USD Source
Operating Cash Flow: -111173000 USD Source
Capital Expenditure: 10696000 USD Source
Capital Expenditure: 6090000 USD Source

Cash and cash equivalents: 323 million USD 2013-06-30 Source
Exact value

323068000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 73.1 million shares 2013-06-30 Source
Exact value

73056158 shares

Reported share-count change

12.68% · 8.22 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

64833001 shares · 2012-06-30· Source
73056158 shares · 2013-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

516 million USD

2012-07-01 – 2013-06-30

Exact inputs and evidence

Revenue: 89511000 USD · 2012-07-01 – 2012-09-30 Source
Revenue: 127918000 USD · 2012-10-01 – 2012-12-31 Source
Revenue: 145492000 USD · 2013-01-01 – 2013-03-31 Source
Revenue: 153026000 USD · 2013-04-01 – 2013-06-30 Source

Net income

-112 million USD

2012-07-01 – 2013-06-30

Exact inputs and evidence

Net income: 17396000 USD · 2012-07-01 – 2012-09-30 Source
Net income: -42922000 USD · 2012-10-01 – 2012-12-31 Source
Net income: -33671000 USD · 2013-01-01 – 2013-03-31 Source
Net income: -53168000 USD · 2013-04-01 – 2013-06-30 Source

Operating cash flow

-258 million USD

2012-07-01 – 2013-06-30

Exact inputs and evidence

Operating cash flow: -129486000 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -86977000 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -230479000 USD · 2012-01-01 – 2012-12-31 Source
Operating cash flow: -129486000 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -111173000 USD · 2013-01-01 – 2013-03-31 Source
Operating cash flow: -114524000 USD · 2013-01-01 – 2013-06-30 Source
Operating cash flow: -111173000 USD · 2013-01-01 – 2013-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-08-09.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2012-12-31
Operating income: 11 of 11 periods available· newest 2012-12-31
Net income: 11 of 11 periods available· newest 2012-12-31
Operating cash flow: 11 of 11 periods available· newest 2012-12-31
Capital expenditure: 10 of 11 periods available· newest 2012-12-31
Total assets: 10 of 11 periods available· newest 2012-12-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2012-12-31
Current liabilities: 11 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2012-12-31
long term debt: No compatible figures in this window
Shares outstanding: 4 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-19%

Prior period

USD 447.17 million

2011-01-01 – 2011-12-31
Current period

USD 362.17 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

362165000 − 447174000 = -85009000 USD

447174000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
362165000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ONYX PHARMACEUTICALS INC · 2012-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Year-over-year change in Revenue: -85009000 USD Concept: fundies:Revenue Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 362165000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#949630 Filing: 000104746913001966 Input fundies:Revenue: 447174000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#945877 Filing: 000104746913001966
The citation records this snapshot. The page link may show a newer release later.
Net income
-346.7%

Prior period

USD 76.11 million

2011-01-01 – 2011-12-31
Current period

−USD 187.79 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-187787000 − 76110000 = -263897000 USD

76110000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-187787000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ONYX PHARMACEUTICALS INC · 2012-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Year-over-year change in Net income: -263897000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -187787000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#951664 Filing: 000104746913001966 Input fundies:NetIncome: 76110000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#949395 Filing: 000104746913001966
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-556%

Prior period

USD 50.55 million

2011-01-01 – 2011-12-31
Current period

−USD 230.48 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-230479000 − 50545000 = -281024000 USD

50545000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-230479000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ONYX PHARMACEUTICALS INC · 2012-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Year-over-year change in Operating cash flow: -281024000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -230479000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#1811537 Filing: 000104746913001966 Input fundies:OperatingCashFlow: 50545000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#956735 Filing: 000104746913001966
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-24.7%

Prior period

USD 15.11 million

2011-01-01 – 2011-12-31
Current period

USD 11.37 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

11374000 − 15107000 = -3733000 USD

15107000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
11374000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ONYX PHARMACEUTICALS INC · 2012-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Year-over-year change in Capital expenditure: -3733000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 11374000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#1812520 Filing: 000104746913001966 Input fundies:CapitalExpenditure: 15107000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#958840 Filing: 000104746913001966
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue USD 362.17 million 100% of revenue
Cost of revenue USD 1.33 million 0.4% of revenue
Operating expenses USD 629.25 million 174% of revenue
Operating income −USD 267.09 million −74% of revenue
Tax, interest and other Derived −USD 79.3 million −22% of revenue
Net income −USD 187.79 million −52% of revenue

Cash

Operating cash flow −USD 230.48 million −64% of revenue
Capital expenditure USD 11.37 million 3.1% of revenue
Free cash flow Derived −USD 241.85 million −67% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 Not shown: operating income or net income is not reported.
2004 Operating loss: operating costs were 10,084% of revenue.
2005 Operating loss: operating costs were 10,279% of revenue.
2006 Operating loss: operating costs were 455% of revenue.
2007 Operating loss: operating costs were 159% of revenue.
2008 Operating loss: operating costs were 105% of revenue.
2009 92%
2010 Operating loss: operating costs were 121% of revenue.
2011 17%78%
2012 Operating loss: operating costs were 174% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2003-01-01 – 2003-12-31	0	45528000 Derived	-45528000	-559000 Derived	-44969000	-37938000 Derived	Source 2003-01-01 – 2003-12-31: 0 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -45528000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -44969000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -37781000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 157000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	500000	50420000 Derived	-49920000	-3164000 Derived	-46756000	-48518000 Derived	Source 2004-01-01 – 2004-12-31: 500000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -49920000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -46756000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -46945000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 1573000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	1000000	102791000 Derived	-101791000	-6617000 Derived	-95174000	-73221000 Derived	Source 2005-01-01 – 2005-12-31: 1000000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -101791000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -95174000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -72597000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 624000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	29524000	134188000 Derived	-104664000	-11983000 Derived	-92681000	-100864000 Derived	Source 2006-01-01 – 2006-12-31: 29524000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -104664000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -92681000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -100245000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 619000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	90429000	143852000 Derived	-53423000	-19256000 Derived	-34167000	-29139000 Derived	Source 2007-01-01 – 2007-12-31: 90429000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -53423000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -34167000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -26441000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 2698000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	194343000	204743000 Derived	-10400000	-12348000 Derived	1948000	-9995000 Derived	Source 2008-01-01 – 2008-12-31: 194343000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -10400000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 1948000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -8445000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 1550000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	251390000	231166000 Derived	20224000	4063000 Derived	16161000	Unavailable	Source 2009-01-01 – 2009-12-31: 251390000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 20224000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 16161000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 35072000 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	324515000	392837000 Derived	-68322000	16525000 Derived	-84847000	21367000 Derived	Source 2010-01-01 – 2010-12-31: 324515000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -68322000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -84847000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 28357000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 6990000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	447174000	348868000 Derived	98306000	22196000 Derived	76110000	35438000 Derived	Source 2011-01-01 – 2011-12-31: 447174000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 98306000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 76110000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 50545000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 15107000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	362165000	629252000 Derived	-267087000	-79300000 Derived	-187787000	-241853000 Derived	Source 2012-01-01 – 2012-12-31: 362165000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -267087000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -187787000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -230479000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 11374000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 362.2M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Revenue	0	Revenue: 0 Open source
20042004-12-31	Revenue	500000	Revenue: 500000 Open source
20052005-12-31	Revenue	1000000	Revenue: 1000000 Open source
20062006-12-31	Revenue	29524000	Revenue: 29524000 Open source
20072007-12-31	Revenue	90429000	Revenue: 90429000 Open source
20082008-12-31	Revenue	194343000	Revenue: 194343000 Open source
20092009-12-31	Revenue	251390000	Revenue: 251390000 Open source
20102010-12-31	Revenue	324515000	Revenue: 324515000 Open source
20112011-12-31	Revenue	447174000	Revenue: 447174000 Open source
20122012-12-31	Revenue	362165000	Revenue: 362165000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-19% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 2715000 Open source
20042004-12-31	Year over year	No prior comparable period	Revenue: 500000 Open source Revenue: 0 Open source
20052005-12-31	Year over year	100%	Revenue: 1000000 Open source Revenue: 500000 Open source
20062006-12-31	Year over year	2,852.4%	Revenue: 29524000 Open source Revenue: 1000000 Open source
20072007-12-31	Year over year	206.3%	Revenue: 90429000 Open source Revenue: 29524000 Open source
20082008-12-31	Year over year	114.9%	Revenue: 194343000 Open source Revenue: 90429000 Open source
20092009-12-31	Year over year	29.4%	Revenue: 251390000 Open source Revenue: 194343000 Open source
20102010-12-31	Year over year	29.1%	Revenue: 324515000 Open source Revenue: 251390000 Open source
20112011-12-31	Year over year	37.8%	Revenue: 447174000 Open source Revenue: 324515000 Open source
20122012-12-31	Year over year	-19%	Revenue: 362165000 Open source Revenue: 447174000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -73.7% 2012

Net margin -51.9% 2012

Free cash flow margin -66.8% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Operating margin	Not reported	Operating Income: -45528000 Open source Revenue: 0 Open source
20042004-12-31	Operating margin	-9,984%	Operating Income: -49920000 Open source Revenue: 500000 Open source
20052005-12-31	Operating margin	-10,179.1%	Operating Income: -101791000 Open source Revenue: 1000000 Open source
20062006-12-31	Operating margin	-354.5%	Operating Income: -104664000 Open source Revenue: 29524000 Open source
20072007-12-31	Operating margin	-59.1%	Operating Income: -53423000 Open source Revenue: 90429000 Open source
20082008-12-31	Operating margin	-5.4%	Operating Income: -10400000 Open source Revenue: 194343000 Open source
20092009-12-31	Operating margin	8%	Operating Income: 20224000 Open source Revenue: 251390000 Open source
20102010-12-31	Operating margin	-21.1%	Operating Income: -68322000 Open source Revenue: 324515000 Open source
20112011-12-31	Operating margin	22%	Operating Income: 98306000 Open source Revenue: 447174000 Open source
20122012-12-31	Operating margin	-73.7%	Operating Income: -267087000 Open source Revenue: 362165000 Open source
20032003-12-31	Net margin	Not reported	Net Income: -44969000 Open source Revenue: 0 Open source
20042004-12-31	Net margin	-9,351.2%	Net Income: -46756000 Open source Revenue: 500000 Open source
20052005-12-31	Net margin	-9,517.4%	Net Income: -95174000 Open source Revenue: 1000000 Open source
20062006-12-31	Net margin	-313.9%	Net Income: -92681000 Open source Revenue: 29524000 Open source
20072007-12-31	Net margin	-37.8%	Net Income: -34167000 Open source Revenue: 90429000 Open source
20082008-12-31	Net margin	1%	Net Income: 1948000 Open source Revenue: 194343000 Open source
20092009-12-31	Net margin	6.4%	Net Income: 16161000 Open source Revenue: 251390000 Open source
20102010-12-31	Net margin	-26.1%	Net Income: -84847000 Open source Revenue: 324515000 Open source
20112011-12-31	Net margin	17%	Net Income: 76110000 Open source Revenue: 447174000 Open source
20122012-12-31	Net margin	-51.9%	Net Income: -187787000 Open source Revenue: 362165000 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -37781000 Open source Capital Expenditure: 157000 Open source
20042004-12-31	Free cash flow margin	-9,703.6%	Revenue: 500000 Open source Operating Cash Flow: -46945000 Open source Capital Expenditure: 1573000 Open source
20052005-12-31	Free cash flow margin	-7,322.1%	Revenue: 1000000 Open source Operating Cash Flow: -72597000 Open source Capital Expenditure: 624000 Open source
20062006-12-31	Free cash flow margin	-341.6%	Revenue: 29524000 Open source Operating Cash Flow: -100245000 Open source Capital Expenditure: 619000 Open source
20072007-12-31	Free cash flow margin	-32.2%	Revenue: 90429000 Open source Operating Cash Flow: -26441000 Open source Capital Expenditure: 2698000 Open source
20082008-12-31	Free cash flow margin	-5.1%	Revenue: 194343000 Open source Operating Cash Flow: -8445000 Open source Capital Expenditure: 1550000 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 251390000 Open source Operating Cash Flow: 35072000 Open source
20102010-12-31	Free cash flow margin	6.6%	Revenue: 324515000 Open source Operating Cash Flow: 28357000 Open source Capital Expenditure: 6990000 Open source
20112011-12-31	Free cash flow margin	7.9%	Revenue: 447174000 Open source Operating Cash Flow: 50545000 Open source Capital Expenditure: 15107000 Open source
20122012-12-31	Free cash flow margin	-66.8%	Revenue: 362165000 Open source Operating Cash Flow: -230479000 Open source Capital Expenditure: 11374000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -230.5M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Operating cash flow	-37781000	Operating Cash Flow: -37781000 Open source
20042004-12-31	Operating cash flow	-46945000	Operating Cash Flow: -46945000 Open source
20052005-12-31	Operating cash flow	-72597000	Operating Cash Flow: -72597000 Open source
20062006-12-31	Operating cash flow	-100245000	Operating Cash Flow: -100245000 Open source
20072007-12-31	Operating cash flow	-26441000	Operating Cash Flow: -26441000 Open source
20082008-12-31	Operating cash flow	-8445000	Operating Cash Flow: -8445000 Open source
20092009-12-31	Operating cash flow	35072000	Operating Cash Flow: 35072000 Open source
20102010-12-31	Operating cash flow	28357000	Operating Cash Flow: 28357000 Open source
20112011-12-31	Operating cash flow	50545000	Operating Cash Flow: 50545000 Open source
20122012-12-31	Operating cash flow	-230479000	Operating Cash Flow: -230479000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -241.9M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Free cash flow	-37938000	Operating Cash Flow: -37781000 Open source Capital Expenditure: 157000 Open source
20042004-12-31	Free cash flow	-48518000	Operating Cash Flow: -46945000 Open source Capital Expenditure: 1573000 Open source
20052005-12-31	Free cash flow	-73221000	Operating Cash Flow: -72597000 Open source Capital Expenditure: 624000 Open source
20062006-12-31	Free cash flow	-100864000	Operating Cash Flow: -100245000 Open source Capital Expenditure: 619000 Open source
20072007-12-31	Free cash flow	-29139000	Operating Cash Flow: -26441000 Open source Capital Expenditure: 2698000 Open source
20082008-12-31	Free cash flow	-9995000	Operating Cash Flow: -8445000 Open source Capital Expenditure: 1550000 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: 35072000 Open source
20102010-12-31	Free cash flow	21367000	Operating Cash Flow: 28357000 Open source Capital Expenditure: 6990000 Open source
20112011-12-31	Free cash flow	35438000	Operating Cash Flow: 50545000 Open source Capital Expenditure: 15107000 Open source
20122012-12-31	Free cash flow	-241853000	Operating Cash Flow: -230479000 Open source Capital Expenditure: 11374000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-12-31	Liabilities / assets	Not reported	Total Assets: 109138000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 215546000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 294665000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 286246000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 484083000 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 509767000 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 1324680000 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 1352635000 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 1411724000 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 1351571000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.24× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Current assets / current liabilities	6.94×	Current Assets: 108445000 Open source Current Liabilities: 15619000 Open source
20042004-12-31	Current assets / current liabilities	13.72×	Current Assets: 213431000 Open source Current Liabilities: 15558000 Open source
20052005-12-31	Current assets / current liabilities	6.83×	Current Assets: 283103000 Open source Current Liabilities: 41425000 Open source
20062006-12-31	Current assets / current liabilities	12.07×	Current Assets: 279898000 Open source Current Liabilities: 23199000 Open source
20072007-12-31	Current assets / current liabilities	42.01×	Current Assets: 480656000 Open source Current Liabilities: 11441000 Open source
20082008-12-31	Current assets / current liabilities	13.87×	Current Assets: 462059000 Open source Current Liabilities: 33304000 Open source
20092009-12-31	Current assets / current liabilities	5.93×	Current Assets: 638723000 Open source Current Liabilities: 107778000 Open source
20102010-12-31	Current assets / current liabilities	8.86×	Current Assets: 645184000 Open source Current Liabilities: 72860000 Open source
20112011-12-31	Current assets / current liabilities	6.55×	Current Assets: 731849000 Open source Current Liabilities: 111792000 Open source
20122012-12-31	Current assets / current liabilities	5.24×	Current Assets: 687956000 Open source Current Liabilities: 131369000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2003-01-01 – 2003-12-31	−USD 44.97 million Exact value Exact value: -44969000 USD 2003-01-01 – 2003-12-31: -44969000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2003-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: -44969000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -44969000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-06-000122.txt#12323 The citation records this snapshot. The page link may show a newer release later.	−USD 37.78 million Exact value Exact value: -37781000 USD 2003-01-01 – 2003-12-31: -37781000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2003-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: -37781000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37781000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-06-000122.txt#12680 The citation records this snapshot. The page link may show a newer release later.	USD 157,000 Exact value Exact value: 157000 USD 2003-01-01 – 2003-12-31: 157000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2003-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 157000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 157000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-06-000122.txt#12789 The citation records this snapshot. The page link may show a newer release later.	−USD 37.94 million Calculation and evidence -37781000 − 157000 USD Exact free cash flow: -37938000 USD 2003-01-01 – 2003-12-31: -37781000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 157000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2003-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: -37938000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37781000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-06-000122.txt#12680 Input fundies:CapitalExpenditure: 157000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-06-000122.txt#12789 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 46.76 million Exact value Exact value: -46756000 USD 2004-01-01 – 2004-12-31: -46756000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2004-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: -46756000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46756000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-07-000084.txt#21325 The citation records this snapshot. The page link may show a newer release later.	−USD 46.95 million Exact value Exact value: -46945000 USD 2004-01-01 – 2004-12-31: -46945000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2004-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: -46945000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46945000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-07-000084.txt#22163 The citation records this snapshot. The page link may show a newer release later.	USD 1.57 million Exact value Exact value: 1573000 USD 2004-01-01 – 2004-12-31: 1573000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2004-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 1573000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1573000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-07-000084.txt#22426 The citation records this snapshot. The page link may show a newer release later.	−USD 48.52 million Calculation and evidence -46945000 − 1573000 USD Exact free cash flow: -48518000 USD 2004-01-01 – 2004-12-31: -46945000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 1573000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2004-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: -48518000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46945000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-07-000084.txt#22163 Input fundies:CapitalExpenditure: 1573000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950149-07-000084.txt#22426 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 95.17 million Exact value Exact value: -95174000 USD 2005-01-01 – 2005-12-31: -95174000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2005-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: -95174000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -95174000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-08-003765.txt#20033 The citation records this snapshot. The page link may show a newer release later.	−USD 72.6 million Exact value Exact value: -72597000 USD 2005-01-01 – 2005-12-31: -72597000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2005-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: -72597000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -72597000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-08-003765.txt#20849 The citation records this snapshot. The page link may show a newer release later.	USD 624,000 Exact value Exact value: 624000 USD 2005-01-01 – 2005-12-31: 624000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2005-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 624000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 624000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-08-003765.txt#21105 The citation records this snapshot. The page link may show a newer release later.	−USD 73.22 million Calculation and evidence -72597000 − 624000 USD Exact free cash flow: -73221000 USD 2005-01-01 – 2005-12-31: -72597000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 624000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2005-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: -73221000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -72597000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-08-003765.txt#20849 Input fundies:CapitalExpenditure: 624000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-08-003765.txt#21105 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 92.68 million Exact value Exact value: -92681000 USD 2006-01-01 – 2006-12-31: -92681000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2006-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: -92681000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -92681000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-09-003728.txt#21849 The citation records this snapshot. The page link may show a newer release later.	−USD 100.25 million Exact value Exact value: -100245000 USD 2006-01-01 – 2006-12-31: -100245000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2006-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: -100245000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -100245000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-09-003728.txt#22622 The citation records this snapshot. The page link may show a newer release later.	USD 619,000 Exact value Exact value: 619000 USD 2006-01-01 – 2006-12-31: 619000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2006-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 619000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 619000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-09-003728.txt#22878 The citation records this snapshot. The page link may show a newer release later.	−USD 100.86 million Calculation and evidence -100245000 − 619000 USD Exact free cash flow: -100864000 USD 2006-01-01 – 2006-12-31: -100245000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 619000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2006-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: -100864000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -100245000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-09-003728.txt#22622 Input fundies:CapitalExpenditure: 619000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950134-09-003728.txt#22878 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 34.17 million Exact value Exact value: -34167000 USD 2007-01-01 – 2007-12-31: -34167000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2007-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: -34167000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34167000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950123-10-015780.txt#27536 The citation records this snapshot. The page link may show a newer release later.	−USD 26.44 million Exact value Exact value: -26441000 USD 2007-01-01 – 2007-12-31: -26441000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2007-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: -26441000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26441000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950123-10-015780.txt#28397 The citation records this snapshot. The page link may show a newer release later.	USD 2.7 million Exact value Exact value: 2698000 USD 2007-01-01 – 2007-12-31: 2698000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2007-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 2698000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2698000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950123-10-015780.txt#28696 The citation records this snapshot. The page link may show a newer release later.	−USD 29.14 million Calculation and evidence -26441000 − 2698000 USD Exact free cash flow: -29139000 USD 2007-01-01 – 2007-12-31: -26441000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 2698000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2007-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: -29139000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26441000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950123-10-015780.txt#28397 Input fundies:CapitalExpenditure: 2698000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950123-10-015780.txt#28696 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	USD 1.95 million Exact value Exact value: 1948000 USD 2008-01-01 – 2008-12-31: 1948000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2008-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: 1948000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1948000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000095012311017166/onxx-20101231.xml#807948 Filing: 000095012311017166 The citation records this snapshot. The page link may show a newer release later.	−USD 8.45 million Exact value Exact value: -8445000 USD 2008-01-01 – 2008-12-31: -8445000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2008-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: -8445000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8445000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000095012311017166/onxx-20101231.xml#807397 Filing: 000095012311017166 The citation records this snapshot. The page link may show a newer release later.	USD 1.55 million Exact value Exact value: 1550000 USD 2008-01-01 – 2008-12-31: 1550000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2008-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 1550000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1550000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950123-11-017166.txt#29578 The citation records this snapshot. The page link may show a newer release later.	−USD 10 million Calculation and evidence -8445000 − 1550000 USD Exact free cash flow: -9995000 USD 2008-01-01 – 2008-12-31: -8445000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 1550000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2008-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: -9995000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8445000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000095012311017166/onxx-20101231.xml#807397 Filing: 000095012311017166 Input fundies:CapitalExpenditure: 1550000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/0000950123-11-017166.txt#29578 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 16.16 million Exact value Exact value: 16161000 USD 2009-01-01 – 2009-12-31: 16161000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2009-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: 16161000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 16161000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000095012311017166/onxx-20101231.xml#808851 Filing: 000095012311017166 The citation records this snapshot. The page link may show a newer release later.	USD 35.07 million Exact value Exact value: 35072000 USD 2009-01-01 – 2009-12-31: 35072000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2009-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: 35072000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 35072000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000095012311017166/onxx-20101231.xml#807582 Filing: 000095012311017166 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 84.85 million Exact value Exact value: -84847000 USD 2010-01-01 – 2010-12-31: -84847000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2010-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: -84847000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -84847000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#949512 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	USD 28.36 million Exact value Exact value: 28357000 USD 2010-01-01 – 2010-12-31: 28357000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2010-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: 28357000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 28357000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#956950 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	USD 6.99 million Exact value Exact value: 6990000 USD 2010-01-01 – 2010-12-31: 6990000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2010-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 6990000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6990000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#959015 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	USD 21.37 million Calculation and evidence 28357000 − 6990000 USD Exact free cash flow: 21367000 USD 2010-01-01 – 2010-12-31: 28357000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 6990000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2010-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: 21367000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 28357000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#956950 Filing: 000104746913001966 Input fundies:CapitalExpenditure: 6990000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#959015 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	USD 76.11 million Exact value Exact value: 76110000 USD 2011-01-01 – 2011-12-31: 76110000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2011-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: 76110000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 76110000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#949395 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	USD 50.55 million Exact value Exact value: 50545000 USD 2011-01-01 – 2011-12-31: 50545000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2011-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: 50545000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 50545000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#956735 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	USD 15.11 million Exact value Exact value: 15107000 USD 2011-01-01 – 2011-12-31: 15107000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2011-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 15107000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15107000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#958840 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	USD 35.44 million Calculation and evidence 50545000 − 15107000 USD Exact free cash flow: 35438000 USD 2011-01-01 – 2011-12-31: 50545000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 15107000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2011-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: 35438000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 50545000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#956735 Filing: 000104746913001966 Input fundies:CapitalExpenditure: 15107000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#958840 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 187.79 million Exact value Exact value: -187787000 USD 2012-01-01 – 2012-12-31: -187787000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONYX PHARMACEUTICALS INC · 2012-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Net Income: -187787000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -187787000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#951664 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	−USD 230.48 million Exact value Exact value: -230479000 USD 2012-01-01 – 2012-12-31: -230479000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONYX PHARMACEUTICALS INC · 2012-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Operating Cash Flow: -230479000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -230479000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#1811537 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	USD 11.37 million Exact value Exact value: 11374000 USD 2012-01-01 – 2012-12-31: 11374000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONYX PHARMACEUTICALS INC · 2012-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Capital Expenditure: 11374000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11374000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#1812520 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.	−USD 241.85 million Calculation and evidence -230479000 − 11374000 USD Exact free cash flow: -241853000 USD 2012-01-01 – 2012-12-31: -230479000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 11374000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONYX PHARMACEUTICALS INC · 2012-12-31 ONYX PHARMACEUTICALS INC (edgar:1012140) Free cash flow: -241853000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:54:01Z Snapshot: 7ec3776b1086194e1be37aed54cd06568891eaee4d6ff4b3090d5b728b90d4d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1012140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -230479000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#1811537 Filing: 000104746913001966 Input fundies:CapitalExpenditure: 11374000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/onxx-20121231.xml#1812520 Filing: 000104746913001966 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

71 filings · 1,386 latest values · 1,386 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001012140, 1012140, edgar:1012140

Also known as ONYX PHARMACEUTICALS INC

ONYX PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation